Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results